ETFMG Treatments Testing and Advancements ETF (GERM)
|Ex-Dividend Date||Sep 20, 2023|
|Day's Range||17.57 - 17.86|
|Inception Date||Jun 17, 2020|
About GERMFund Home Page
The ETFMG Treatments Testing and Advancements ETF (GERM) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a tier-weighted, narrow index of US-listed, global biotech companies that are engaged in the testing and treatments of infectious diseases. GERM was launched on Jun 17, 2020 and is issued by ETFMG.
Top 10 Holdings50.43% of assets
|Quest Diagnostics Incorporated||DGX||6.91%|
|Laboratory Corporation of America Holdings||LH||6.90%|
|Alnylam Pharmaceuticals, Inc.||ALNY||5.63%|
|Zai Lab Limited||ZLAB||4.73%|
|Immunocore Holdings plc||IMCR||4.13%|
|Dynavax Technologies Corporation||DVAX||3.93%|
|Sep 20, 2023||$0.040||Sep 22, 2023|
|Jun 21, 2023||$0.060||Jun 23, 2023|
|Mar 22, 2023||$0.090||Mar 24, 2023|
|Dec 28, 2022||$0.0286||Dec 30, 2022|
|Sep 21, 2022||$0.060||Sep 23, 2022|
|Jun 22, 2022||$0.050||Jun 24, 2022|
In June, the ETF industry learned that issuer ETF Managers Group would be selling its funds to Amplify ETFs. The transaction, once completed, will bring Amplify's total AUM to $8 billion invested acro...
The week ending Friday, July 21, has been busy for the ETF industry, though launches were muted. A total of seven funds rolled out, which suggests the market could be entering some kind of summer slum...
Biotechnology sector-related exchange traded funds retreated with Novavax Inc. (NasdaqGS: NVAX), plunging after the vaccine developer cut its 2022 revenue guidance in half. On Tuesday, the iShares Gen...
Moderna Inc (NasdaqGS: MRNA) shares surged Wednesday, lifting biotechnology sector-related exchange traded funds, after the pharmaceutical company revealed better-than-expected profit and revenue in i...
There was big news on the coronavirus vaccine front Monday when Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) said their vaccine delivered an impressive showing in Phase 3 trials. What Happened: Alon...
Investing in coronavirus themed ETFs which focus on companies involved in testing and treatment
ETF Managers Group CEO Sam Masucci discusses GERM an ETF that invests in companies that are focused on COVID-19 treatment and testing.
Exchange-traded funds with exposure to biotech stocks rocketed higher Tuesday on hopeful news about treatments for COVID-19.
The newest health care exchange-traded fund is unique in that three stalwarts of other industry funds aren’t even among its top holdings.